Format

Send to

Choose Destination
Am J Trop Med Hyg. 2015 Nov;93(5):1110-6. doi: 10.4269/ajtmh.15-0185. Epub 2015 Aug 24.

Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium.

Author information

1
Division of Infectious Diseases, University of California, San Francisco, California; Division of Infectious Diseases and Travel Medicine, Georgetown University, Washington, District of Columbia; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia; Johns Hopkins Travel and Tropical Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland; Division of Pediatric Infectious Diseases, Bronx Lebanon Hospital Center, Bronx, New York; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York; Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts; Center for Health Quality, Outcomes and Economics Research, Bedford Veterans Affairs Medical Center, Bedford, Massachusetts; Travelers' Advice and Immunization Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
2
Division of Infectious Diseases, University of California, San Francisco, California; Division of Infectious Diseases and Travel Medicine, Georgetown University, Washington, District of Columbia; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia; Johns Hopkins Travel and Tropical Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland; Division of Pediatric Infectious Diseases, Bronx Lebanon Hospital Center, Bronx, New York; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York; Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts; Center for Health Quality, Outcomes and Economics Research, Bedford Veterans Affairs Medical Center, Bedford, Massachusetts; Travelers' Advice and Immunization Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts rclarocque@partners.org.

Abstract

An increasing number of immunocompromised individuals are pursuing international travel, and a better understanding of their international travel patterns and pretravel health care is needed. We evaluated the clinical features, itineraries, and pretravel health care of 486 immunocompromised international travelers seen at Global TravEpiNet sites from January 2009 to June 2012. We used bivariate analyses and logistic regressions using random intercept models to compare demographic and travel characteristics, vaccines administered, and medications prescribed for immunocompromised travelers versus 30,702 immunocompetent travelers. Immunocompromised travelers pursued itineraries that were largely similar to those of immunocompetent travelers, with nearly one-third of such travelers visiting countries with low human development indices. Biological agents, including tumor necrosis factor blockers, were commonly used immunosuppressive medications among immunocompromised travelers. A strong collaboration between travel-medicine specialists, primary care doctors, and specialist physicians is needed to prepare immunocompromised people for international travel. Incorporating routine questioning and planning regarding travel into the primary care visits of immunocompromised people may be useful.

PMID:
26304922
PMCID:
PMC4703284
DOI:
10.4269/ajtmh.15-0185
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Ingenta plc Icon for PubMed Central
Loading ...
Support Center